The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Emyria Limited (ASX:EMD) Share Price | Latest News – The Market Online, a trailblazer in mental health treatment innovation, has teamed up with charity group ‘Reach Wellness’ to spearhead a pivotal study to support post-traumatic stress disorder (PTSD) sufferers.

The research aims to assess the effectiveness of Emyria’s MDMA-assisted therapy (MDMA-AT) program, alongside Reach Wellness’ support initiatives, for those battling PTSD.

The collaboration underscores Emyria’s commitment to pioneering solutions in mental health care. Since launching community-based MDMA-assisted therapy trials in October 2023, the company’s lead psychiatrist has obtained Authorised Prescriber status, allowing Emyria to offer MDMA-assisted therapy for PTSD under stringent regulatory oversight.

Under the research study agreement, Reach Wellness will launch a fundraising campaign to cover treatment and follow-up expenses for an initial group of 50 screened first responders eligible for MDMA-AT. This initiative represents a significant investment in mental health care, estimated at $1.5 million, and showcases a collective effort to explore new therapies for those who dedicate their lives to public service.

With over 1 million Australians affected by PTSD, the partnership responds to the pressing national mental health challenge, particularly among first responders and veterans. Traditional treatments may not suffice for all sufferers, emphasizing the need for innovative approaches like MDMA-AT, which has already shown promise in Phase 3 clinical trials in the USA.

“We are committed to evaluating the impact of emerging approaches like MDMA-Assisted Therapy and the team at Reach shares our vision and is committed to backing it financially, with the support of its generous donors,” Emyria CEO Dr Michael Winlo said.

As Emyria expands its clinical facilities and pool of prescribers with the support of Reach Wellness, the company said it is poised to develop scalable and commercially viable mental health solutions, offering hope for a brighter future for those impacted by PTSD.

EMD has been trading at 6.3 cents.

EMD by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Index achieves highest close in history | September 20, 2024

The ASX200 closed up a fifth of a percent at 8,209 points as the Index finished…
Federal Reserve logo on money

Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear

Well, it finally happened – the US Fed cut interest rates this week, and we got…
The Market Online Video

ASX Market Update: Record high as Index follows Wall Street surge | September 20, 2024

The ASX200 has been up 0.3% at 8,220 points after hitting an new all time high…
Copper plant concept AI stock

Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025

Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025…